GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026
GeneDx GeneDx (US:WGS) Businesswire·2026-02-23 11:30

Core Viewpoint - GeneDx Holdings Corp. reported its financial results for the fourth quarter and full year of 2025, indicating significant developments in its performance and strategic direction [1]. Financial Performance - The company disclosed its financial results for Q4 and the entire year of 2025, highlighting key metrics that reflect its operational efficiency and market position [1].

GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026 - Reportify